Company Description
ZimVie Inc., together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide.
It operates through two segments, The Dental Segment and The Spine Segment. The company offers dental implant systems, prosthetic and abutment products, surgical instrumentation, and kits; and patient-specific restorative solutions, such as abutments, bars, implant bridges, and hybrid restorations under the BellaTek brand name.
It provides bone grafts, barrier membranes, and collagen wound care products; virtual treatment planning services, guided surgery solutions, CAD/CAM workflow systems, and intra-oral scanners; and Implant Concierge, a web-based treatment planning and surgery guide service.
In addition, the company designs, manufactures, and distributes spinal fusion implants, instrumentation for various spinal procedures, biologics, and bone healing technologies.
Further, it provides MIS solutions that deliver implant and instrumentation systems; and motion preservation solutions that offer non-fusion alternatives for cervical disc implant or growth modulation for anterior vertebral body tethering.
The company sells its products to oral surgeons, dental specialists, general dentists, dental laboratories, and other dental organizations, including DSOs, as well as educational, medical, and governmental entities, hospitals, and surgery centers through direct sales representatives, agents, and distributors.
ZimVie Inc. was incorporated in 2021 and is headquartered in Westminster, Colorado.
| Country | United States |
| Founded | 2021 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 2,600 |
| CEO | Vafa Jamali |
Contact Details
Address: 10225 Westmoor Drive Westminster, Colorado 80021 United States | |
| Phone | 303-443-7500 |
| Website | zimvie.com |
Stock Details
| Ticker Symbol | ZIMV |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001876588 |
| CUSIP Number | 98888T107 |
| ISIN Number | US98888T1079 |
| SIC Code | 3843 |
Key Executives
| Name | Position |
|---|---|
| Vafa Jamali | President, Chief Executive Officer and Director |
| Richard J. Heppenstall | Executive Vice President, Chief Financial Officer and Treasurer |
| Heather Kidwell | Senior Vice President, Chief Legal, Human Resources and Compliance Officer and Corporate Secretary |
| Indraneel Kanaglekar | Senior Vice President and President of Global Dental |
| Rebecca A. Whitney | Senior Vice President and President of Global Spine |
| Sandra Schneider | Chief Accounting Officer |
| Steve Rondeau | Senior Vice President and Chief Information Officer |
| Laura Driscoll | Vice President of Communications |
| Ann Vu | Senior Vice President of Regulatory Affairs, Quality Assurance and Clinical |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 4, 2024 | 8-K/A | [Amend] Current report |
| Apr 2, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 1, 2024 | 8-K | Current Report |
| Mar 29, 2024 | ARS | Filing |
| Mar 29, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Mar 29, 2024 | DEF 14A | Other definitive proxy statements |
| Mar 4, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| Feb 28, 2024 | 10-K | Annual Report |
| Feb 28, 2024 | 8-K | Current Report |
| Feb 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |